EP Patent

EP0511866A2 — Process for the crystallization of cyclic lipopeptides

Assigned to Merck and Co Inc · Expires 1992-11-04 · 34y expired

What this patent protects

A process for obtaining a compound of the formula <CHEM> in crystalline form by solubilizing the compound in warm aqueous n-propanol and then allowing the solution to stand at ambient temperature until crystal formation is substantially complete is described. The crystallin…

USPTO Abstract

A process for obtaining a compound of the formula <CHEM> in crystalline form by solubilizing the compound in warm aqueous n-propanol and then allowing the solution to stand at ambient temperature until crystal formation is substantially complete is described. The crystalline compound obtained thereby is also described. <IMAGE>

Drugs covered by this patent

Patent Metadata

Patent number
EP0511866A2
Jurisdiction
EP
Classification
—
Expires
1992-11-04
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.